This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...
Figure 1: Domain structure ... ubiquitin-like molecule with two ubiquitin fold repeats, contains the same C-terminal sequence as ubiquitin. Isopeptide versus peptide cleavage. The chemical ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
Models based on genetically determined set points explained some of the weight control mechanisms, but exact molecular underpinnings remained ... cholecystokinin; PYY, peptide YY; GLP-1, glucagon-like ...
The absolute risk for thyroid cancer is low among patients receiving GLP-1 RA therapy, but risk is elevated in the first year of treatment.
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers.
A large cohort study examining more than 125,000 adults in the U.S. found that the majority of patients discontinue GLP-1 RA therapy within the first year, with those without Type 2 diabetes showing ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
Quantum spin liquids (QSLs) are fascinating and mysterious states of matter that have intrigued scientists for decades. First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results